Antibody Desensitization Therapy in Highly Sensitized Lung Transplant Candidates
Open accessThe DOI matches its Crossref record.
Abstract
As HLAs antibody detection technology has evolved, there is now detailed HLA antibody information available on prospective transplant recipients. Determining single antigen antibody specificity allows for a calculated panel reactive antibodies (cPRA) value, providing an estimate of the effective donor pool. For broadly sensitized lung transplant candidates (cPRA ≥ 80%), our center adopted a pretransplant multi-modal desensitization protocol in an effort to decrease the cPRA and expand the donor pool. This desensitization protocol included plasmapheresis, solumedrol, bortezomib and rituximab given in combination over 19 days followed by intravenous immunoglobulin. Eight of 18 candidates completed therapy with the primary reasons for early discontinuation being transplant (by avoiding unacceptable antigens) or thrombocytopenia. In a mixed-model analysis, there were no significant changes in PRA or cPRA changes over time with the protocol. A sub-analysis of the median fluorescence intensity (MFI) change indicated a small decline that was significant in antibodies with MFI 5000-10,000. Nine of 18 candidates subsequently had a transplant. Posttransplant survival in these nine recipients was comparable to other pretransplant-sensitized recipients who did not receive therapy. In summary, an aggressive multi-modal desensitization protocol does not significantly reduce pretransplant HLA antibodies in a broadly sensitized lung transplant candidate cohort.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Schwartz, J., Padmanabhan, A., Aqui, N., Balogun, R. A., Connelly‐Smith, L., Delaney, M., Dunbar, N. M., Witt, V., Wu, Y., & Shaz, B. H. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21470 · Cited by 793
Schwartz, J., Winters, J. L., Padmanabhan, A., Balogun, R. A., Delaney, M., Linenberger, M. L., Szczepiorkowski, Z. M., Williams, M. E., Wu, Y., & Shaz, B. H. (2013) · Journal of Clinical Apheresis · doi:10.1002/jca.21276 · Cited by 603
Levine, D. J., Glanville, A. R., Aboyoun, C., Belperio, J., Benden, C., Berry, G. J., Hachem, R., Hayes, D., Neil, D., Reinsmoen, N. L., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2016.01.1223 · Cited by 488
Self-citationSurvival in Sensitized Lung Transplant Recipients With Perioperative Desensitization
Tinckam, K. J., Keshavjee, S., Chaparro, C., Barth, D., Azad, S., Binnie, M., Chow, C. W., de Perrot, M., Pierre, A. F., Waddell, T. K., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13076 · Cited by 161
The mechanisms of rejection in solid organ transplantation
Cozzi, E., Colpo, A., & De Silvestro, G. (2017) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2017.07.005 · Cited by 57
Clinical outcomes of lung transplantation in the presence of donor-specific antibodies
Courtwright, A. M., Cao, S., Wood, I., Mallidi, H. R., Kawasawa, J., Moniodis, A., Ng, J., El-Chemaly, S., & Goldberg, H. J. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201812-869oc · Cited by 39
Michel, E., Galen Hartwig, M., & Sommer, W. (2022) · Thoracic Surgery Clinics · doi:10.1016/j.thorsurg.2021.12.001 · Cited by 6
Metadata
- Authors
- Snyder, L. D., Gray, A. L., Reynolds, J. M., Arepally, G. M., Bedoya, A., Hartwig, M. G., Davis, R. D., Lopes, K. E., Wegner, W. E., Chen, D. F., & Palmer, S. M.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 14
- Issue
- 4
- Pages
- 849-856
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W2142141375
- Cited by
- 109
- References
- 0
- FWCI
- 9.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.